MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis (Q39038746)

8 September 2017

MicroRNA-497 and bufalin act synergistically to inhibit colorectal cancer metastasis (English)

1 reference

8 September 2017

1 reference

1 reference

1 reference

1 reference

Yan-yan Qiu

1

1 reference

8 September 2017

Qiang Hu

2

1 reference

8 September 2017

Qing-feng Tang

3

1 reference

8 September 2017

Wen Feng

4

1 reference

8 September 2017

Song-jiao Hu

5

1 reference

8 September 2017

Bo Liang

6

1 reference

8 September 2017

Wen Peng

7

1 reference

8 September 2017

Pei-hao Yin

8

1 reference

8 September 2017

language of work or name

1 reference

29 December 2013

1 reference

8 September 2017

1 reference

8 September 2017

35

1 reference

8 September 2017

3

1 reference

8 September 2017

2599-2606

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-013-1342-6

8 September 2017

0 references

cites work

Chemotherapy for breast cancer (Review).

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

Novel RNA-based strategies for therapeutic gene silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

Discovery and development of anticancer aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

Engineering RNA for targeted siRNA delivery and medical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

Development of microRNA-145 for therapeutic application in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

Genotype-dependent expression of endothelial nitric oxide synthase (eNOS) and its regulatory proteins in cultured endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

Quantitative real-time PCR protocol for analysis of nuclear receptor signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

Metastamir: the field of metastasis-regulatory microRNA is spreading

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

Switching from repression to activation: microRNAs can up-regulate translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

Identification of differentially expressed microRNAs in human male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

New drugs for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

A family of angiogenic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1342-6

Primary prevention of colorectal cancer. The WHO Collaborating Centre for the Prevention of Colorectal Cancer

21 January 2018

1 reference

12 December 2020

Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer

1 reference

12 December 2020

Bufalin prevents the migration and invasion of T24 bladder carcinoma cells through the inactivation of matrix metalloproteinases and modulation of tight junctions

1 reference

12 December 2020

Bufalin increases sensitivity to AKT/mTOR-induced autophagic cell death in SK-HEP-1 human hepatocellular carcinoma cells

1 reference

12 December 2020

Mechanisms of metastasis

1 reference

12 December 2020

Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: new hope for cancer patients.

1 reference

12 December 2020

Cigarette smoke activates caspase-3 to induce apoptosis of human umbilical venous endothelial cells

1 reference

12 December 2020

MicroRNAs--the micro steering wheel of tumour metastases

1 reference

12 December 2020

Bufalin Induces Reactive Oxygen Species Dependent Bax Translocation and Apoptosis in ASTC-a-1 Cells

1 reference

12 December 2020

Adjuvant Therapy for completely resected Stage II Colon Cancer

1 reference

12 December 2020

10.1007/S13277-013-1342-6

Identifiers

DOI

1 reference

8 September 2017

1 reference